Transcriptional analysis reveals gender-specific changes in the aging of the human immune system

PLoS One. 2013 Jun 11;8(6):e66229. doi: 10.1371/journal.pone.0066229. Print 2013.

Abstract

Aging and gender have a strong influence on the functional capacity of the immune system. In general, the immune response in females is stronger than that in males, but there is scant information about the effect of aging on the gender difference in the immune response. To address this question, we performed a transcriptomic analysis of peripheral blood mononuclear cells derived from elderly individuals (nonagenarians, n = 146) and young controls (aged 19-30 years, n = 30). When compared to young controls, we found 339 and 248 genes that were differentially expressed (p<0.05, fold change >1.5 or <-1.5) in nonagenarian females and males, respectively, 180 of these genes were changed in both genders. An analysis of the affected signaling pathways revealed a clear gender bias: there were 48 pathways that were significantly changed in females, while only 29 were changed in males. There were 24 pathways that were shared between both genders. Our results indicate that female nonagenarians have weaker T cell defenses and a more prominent pro-inflammatory response as compared to males. In males significantly fewer pathways were affected, two of which are known to be regulated by estrogen. These data show that the effects of aging on the human immune system are significantly different in males and females.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged, 80 and over
  • Aging / physiology*
  • Female
  • Gene Expression Profiling / methods
  • Humans
  • Immune System / metabolism*
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Sex Factors
  • Signal Transduction / genetics
  • Signal Transduction / physiology
  • Young Adult

Grants and funding

This work was financially supported by grants from the Academy of Finland (132704) (http://www.aka.fi/eng), the Competitive Research Fund of Pirkanmaa Hospital District (9M017 and 9N013) (http://www.pshp.fi/default.aspx?nodeid=10066&contentlan=2) (MH), European Regional Development Fund (http://www.communities.gov.uk/regeneration/regenerationfunding/europeanregionaldevelopment/), Archimedes Foundation (http://archimedes.ee/), Centre for Translational Genomics of Tartu University (http://www.ctg.ut.ee/) and Estonian targeted grant SF0180021s07 (LT, PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.